| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
RegeneRx Biopharmaceuticals Inc (OTCQB: RGRX)
RGRX Technical Analysis
5
| As on 9th Jun 2023 RGRX STOCK Price closed @ 0.04 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.18 & Strong Sell for SHORT-TERM with Stoploss of 0.22 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RGRXSTOCK Price
| Open | 0.05 | Change | Price | % |
| High | 0.05 | 1 Day | -0.01 | -20.00 |
| Low | 0.04 | 1 Week | 0.00 | 0.00 |
| Close | 0.04 | 1 Month | 0.00 | 0.00 |
| Volume | 31569 | 1 Year | -0.11 | -73.33 |
| 52 Week High 0.29 | 52 Week Low 0.03 | ||||
OTCQB USA Most Active Stocks
| BMIX | 0.01 | % |
| MOBQ | 0.18 | -5.26% |
| FNMA | 0.45 | 0.00% |
| ALPP | 3.56 | -0.80% |
| ALPP | 3.56 | -0.80% |
| SHMP | 0.06 | 0.00% |
| NWBO | 0.73 | 0.00% |
| VPLM | 0.08 | % |
| NLST | 3.72 | -8.60% |
| SRNA | 2.78 | 14.88% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| RGRX Daily Charts |
RGRX Intraday Charts |
Whats New @ Bazaartrend |
RGRX Free Analysis |
|
|
RGRX Important Levels Intraday
| RESISTANCE | 0.06 |
| RESISTANCE | 0.05 |
| RESISTANCE | 0.05 |
| RESISTANCE | 0.05 |
| SUPPORT | 0.03 |
| SUPPORT | 0.03 |
| SUPPORT | 0.03 |
| SUPPORT | 0.02 |
RGRX Forecast May 2024
| 4th UP Forecast | 0.31 |
| 3rd UP Forecast | 0.22 |
| 2nd UP Forecast | 0.17 |
| 1st UP Forecast | 0.12 |
| 1st DOWN Forecast | -0.04 |
| 2nd DOWN Forecast | -0.09 |
| 3rd DOWN Forecast | -0.14 |
| 4th DOWN Forecast | -0.23 |
RGRX Weekly Forecast
| 4th UP Forecast | 0.14 |
| 3rd UP Forecast | 0.11 |
| 2nd UP Forecast | 0.09 |
| 1st UP Forecast | 0.07 |
| 1st DOWN Forecast | 0.01 |
| 2nd DOWN Forecast | -0.01 |
| 3rd DOWN Forecast | -0.03 |
| 4th DOWN Forecast | -0.06 |
RGRX Forecast2024
| 4th UP Forecast | 0.6 |
| 3rd UP Forecast | 0.42 |
| 2nd UP Forecast | 0.31 |
| 1st UP Forecast | 0.2 |
| 1st DOWN Forecast | -0.12 |
| 2nd DOWN Forecast | -0.23 |
| 3rd DOWN Forecast | -0.34 |
| 4th DOWN Forecast | -0.52 |
RegeneRx Biopharmaceuticals Inc ( OTCQB USA Symbol : RGRX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RGRX Business Profile
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue. It has strategic partnerships with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland. Address: 15245 Shady Grove Road, Rockville, MD, United States, 20850
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service